EFFECTIVENESS OF BACTERIAL VAGINOSIS THERAPY IN PREGNANT WOMEN BY OCTENIDINE DIHYDROCHLORIDE ANTISEPTIC
https://doi.org/10.21518/2079-701X-2016-12-21-23
Abstract
One of the first places in the structure of diseases of the female sexual organs is taken by bacterial vaginosis, which, by the literature data, is diagnosed in 30-57% of women of the reproductive age [1, 2]. Bacterial vaginosis is an infectious noninflammatory syndrome characterized by a sharp reduction or lack of lactoflora and its replacement by polymicrobial associations of anaerobes and Gardnerella vaginalis, concentration of which achieves 109–1011 CFU/ml of vaginal discharge [3–5].
About the Authors
O. N. VasilchenkoRussian Federation
PhD in medicine
O. R. Baev
Russian Federation
MD, Prof.
References
1. Кира Е.Ф. Бактериальный вагиноз. М.: МИА, 2012. 472 с. / Kira E.F. Bacterial vaginosis. M.: MIA, 2012, 472 p.
2. Pereira L, Chipato T, Mashu A et. al. Randomized study of vaginal and neonatal cleansing with 1% chlorhexidine. Int. J. Gynaecol. Obstet., 2011 Mar, 112(3): 234-8. doi: 10.1016/j.ijgo.2010.09.009.
3. Sinha A, Sazawal S, Pradhan A et. al. Chlorhexidine skin or cord care for prevention of mortality and infections in neonates. Cochrane Database Syst Rev, 2015 Mar 5, 3: CD007835. doi: 10.1002/14651858.CD007835.pub2.
4. Novakov Mikic A, Budakov D. Comparison of local metronidazole and a local antiseptic in the treatment of bacterial vaginosis. Arch. Gynecol. Obstet., 2010 Jul, 282(1): 43-7. doi: 10.1007/s00404-009-1241-7.
5. Wiegand C, Abel M, Ruth P et .al. pH influence on antibacterial efficacy of common antiseptic substances. Skin Pharmacol. Physiol., 2015, 28(3): 147-58. doi: 10.1159/000367632.
6. Тютюнник В.Л. Патогенез, диагностика и методы лечения бактериального вагиноза. Фарматека, 2005, 2(98): 20-24. / Tyutyunnik V.L. Pathogenesis, diagnostics and methods of therapy of bacterial vaginosis. Farmateka, 2005, 2 (98): 20-24.
7. Briese V, Neumann G, Waldschläger J еt al. Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy. Arch. Gynecol. Obstet., 2011 Mar, 283(3): 585-90. doi: 10.1007/s00404-010-1414-4.
8. Haas DM, Morgan S, Contreras K. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst. Rev, 2014 Dec 21, 12: CD007892. doi: 10.1002/14651858.CD007892.pub5.
9. Hadiati DR, Hakimi M, Nurdiati DS et. al. Skin preparation for preventing infection following caesarean section. Cochrane Database Syst Rev, 2014 Sep 17, 9: CD007462. doi: 10.1002/14651858.CD007462.pub3.
10. Briese V, Neumann G, Waldschläger J et. al. Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy. Arch. Gynecol. Obstet., 2011 Mar, 283(3): 585-90. doi: 10.1007/s00404-010-1414-4.
11. Welk A, Zahedani M, Beyer C et al. Antibacterial and antiplaque efficacy of a commercially available octenidine-containing mouthrinse. Clin. Oral Investig., 2015 Nov 10. [Epub ahead of print].
12. Xu Z, Lai Y, Wu D et al. Antibacterial Effects and Biocompatibility of Titania Nanotubes with Octenidine Dihydrochloride/Poly(lactic-coglycolic acid). Biomed. Res. Int., 2015, 2015: 836939. doi: 10.1155/2015/836939.
13. Müller G, Langer J, Siebert J, Kramer A. Residual antimicrobial effect of chlorhexidine digluconate and octenidine dihydrochloride on reconstructed human epidermis. Skin Pharmacol. Physiol., 2014, 27(1): 1-8. doi: 10.1159/000350172.
14. Swidsinski A, Loening-Baucke V, Swidsinski S et. al. Polymicrobial Gardnerella biofilm resists repeated intravaginal antiseptic treatment in a subset of women with bacterial vaginosis: a preliminary report. Arch. Gynecol. Obstet., 2015 Mar, 291(3): 605-9. doi: 10.1007/s00404-014-3484-1.
Review
For citations:
Vasilchenko ON, Baev OR. EFFECTIVENESS OF BACTERIAL VAGINOSIS THERAPY IN PREGNANT WOMEN BY OCTENIDINE DIHYDROCHLORIDE ANTISEPTIC. Meditsinskiy sovet = Medical Council. 2016;(12):21-23. (In Russ.) https://doi.org/10.21518/2079-701X-2016-12-21-23